Clayton, Dubilier & Rice, a private equity company, completed the acquisition of UDG Healthcare, a provider of commercialisation solutions for health care companies, for $4bn. "UDG has long established itself as a leading provider of high-value services to Pharma and Biotech companies globally, supported by a highly skilled workforce. CD&R has a strong record in partnering with management teams and we look forward to working with the UDG team to build on their success and help accelerate UDG's growth and the development of its services offering to clients," Eric Rouzier, CD&R Partner. On June 25, 2021; Clayton, Dubilier & Rice sweetens bid to acquire UDG Healthcare to $4bn from $3.7bn.